IP Verse

Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates Thereof - EP3583947

The patent EP3583947 was granted to Pfizer on Oct 11, 2023. The application was originally filed on Jan 15, 2015 under application number EP19179577A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3583947

PFIZER
Application Number
EP19179577A
Filing Date
Jan 15, 2015
Status
Granted And Under Opposition
Sep 8, 2023
Grant Date
Oct 11, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANOFI PASTEURJul 11, 2024ZWICKERADMISSIBLE
SK BIOSCIENCEJul 11, 2024ZWICKERADMISSIBLE

Patent Citations (65) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2005EP10258-
DESCRIPTIONEP0372501
DESCRIPTIONEP0378881
DESCRIPTIONEP0427347
DESCRIPTIONEP0471177
DESCRIPTIONEP0594610
DESCRIPTIONUS2006228380
DESCRIPTIONUS2006228381
DESCRIPTIONUS2007184071
DESCRIPTIONUS2007184072
DESCRIPTIONUS2007231340
DESCRIPTIONUS2008102498
DESCRIPTIONUS4709017
DESCRIPTIONUS4912094
DESCRIPTIONUS4950740
DESCRIPTIONUS5057540
DESCRIPTIONUS5614382
DESCRIPTIONUS5843711
DESCRIPTIONUS5917017
DESCRIPTIONUS6113918
DESCRIPTIONUS6194388
DESCRIPTIONUS6207646
DESCRIPTIONUS6214806
DESCRIPTIONUS6218371
DESCRIPTIONUS6239116
DESCRIPTIONUS6339068
DESCRIPTIONUS6455673
DESCRIPTIONWO0018434
DESCRIPTIONWO0037105
DESCRIPTIONWO0039299
DESCRIPTIONWO0056357
DESCRIPTIONWO0061761
DESCRIPTIONWO0172337
DESCRIPTIONWO0198334
DESCRIPTIONWO02091998
DESCRIPTIONWO02098368
DESCRIPTIONWO02098369
DESCRIPTIONWO03024480
DESCRIPTIONWO03054007
DESCRIPTIONWO2004081515
DESCRIPTIONWO2005033148
DESCRIPTIONWO2007026190
DESCRIPTIONWO2008118752
DESCRIPTIONWO2009000826
DESCRIPTIONWO2010125480
DESCRIPTIONWO2011100151
DESCRIPTIONWO9014837
DESCRIPTIONWO9101146
DESCRIPTIONWO9219265
DESCRIPTIONWO9313302
DESCRIPTIONWO9315760
DESCRIPTIONWO9317712
DESCRIPTIONWO9403208
DESCRIPTIONWO9508348
DESCRIPTIONWO9629094
DESCRIPTIONWO9842721
DESCRIPTIONWO9858668
OPPOSITIONWO2014118201
SEARCHEP0157899
SEARCHEP2384765
SEARCHUS2013273098
SEARCHUS5623057
SEARCHUS5714354
SEARCHWO2008157590
SEARCHWO2011110531

Non-Patent Literature (NPL) Citations (24) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BARALDOI et al., Infect Immun, (20040000), vol. 72, pages 4884 - 7-
DESCRIPTION- BEALL B. et al., Journal of Clinical Microbiology, (20060000), vol. 44, no. 3, pages 999 - 1017-
DESCRIPTION- BETHELL et al., Biol. Chern., (19790000), vol. 254, pages 2572 - 4-
DESCRIPTION- C. JONES et al., Carbohydrate Research, (20050000), vol. 340, pages 403 - 409-
DESCRIPTION- CROOKE, S.T. et al., Annu. Rev. Pharmacol. Toxicol., (19960000), vol. 36, pages 107 - 129-
DESCRIPTION- DOE et al., Eur. J. Immunol., (19940000), vol. 24, pages 2369 - 2376-
DESCRIPTION- ERICKSON et al., J. Immunol., (19930000), vol. 151, pages 4189 - 4199-
DESCRIPTION- FALUGI et al., Eur J Immunol, (20010000), vol. 31, pages 3816 - 3824-
DESCRIPTION- HEARN et al., J. Chromatogr, (19810000), vol. 218, pages 509 - 18-
DESCRIPTION- HESTRIN, J. Biol. Chem., (19490000), vol. 180, pages 249 - 261-
DESCRIPTION- HUNZIKER J. et al., Mod. Synth. Methods, (19950000), vol. 7, pages 331 - 417-
DESCRIPTION- JACOBS et al., Clin Infect Dis., (20080000), vol. 47, no. 11, pages 1388 - 1395-
DESCRIPTION- JONESLEMERCINIER, J. Pharmaceutical and Biomedical Analysis, (20020000), vol. 30, pages 1233 - 1247-
DESCRIPTION- KUO et al., Infect Immun, (19950000), vol. 63, pages 2706 - 13-
DESCRIPTION- LEMERCINIERJONES, Carbohydrate Research, (19960000), vol. 296, pages 83 - 96-
DESCRIPTION- UCHIDA et al., J. Biol. Chem., (19730000), vol. 218, pages 3838 - 3844-
DESCRIPTION- UCHIDA, T. et al., Nature New Biology, (19710000), vol. 233, pages 8 - 11-
DESCRIPTION- UHLMANN E. et al., Chem. Rev., Humana Press, (19900000), vol. 90, page 543-
SEARCH- J G HOWARD ET AL, "Studies on Immunological Paralysis: V. THE INFLUENCE OF MOLECULAR WEIGHT ON THE IMMUNOGENICITY, TOLEROGENICITY AND ANTIBODY-NEUTRALIZING ACTIVITY OF TYPE III PNEUMOCOCCAL POLYSACCHARIDE", IMMUNOLOGY., GB, (19710101), vol. 21, no. 3, ISSN 0019-2805, pages 535 - 546, XP055210763 [Y] 1-18 * See e.g. the abstract *-
SEARCH- PER-ERIK JANSSON ET AL, "Structural studies of the capsular polysaccharide from Streptococcus pneumoniae types 15B and 15C", CARBOHYDRATE RESEARCH, (19870401), vol. 162, no. 1, doi:10.1016/0008-6215(87)80205-7, ISSN 0008-6215, pages 111 - 116, XP055210747 [Y] 1-18 * See e.g. the abstract *
SEARCH- BUSSAT B ET AL, "Molecular size characterization of bacterial capsular polysaccharide vaccines by high performance liquid chromatography", BIOLOGICALS, ACADEMIC PRESS LTD., LONDON, GB, vol. 18, no. 2, doi:10.1016/1045-1056(90)90021-Q, ISSN 1045-1056, (19900401), pages 117 - 121, (19900401), XP022954054 [Y] 1-18 * See e.g. the abstract; page 117, right column, first and third paragraphs; and section bridging pages 117 and 118 *
SEARCH- Eirikur Saeland ET AL, "Serum Samples from Infants Vaccinated with a Pneumococcal Conjugate Vaccine, PncT, Protect Mice against Invasive Infection Caused by Streptococcus pneumoniae Serotypes 6A and 6B", The Journal of Infectious Diseases, United States, doi:10.1086/317934, (20010115), pages 253 - 260, URL: http://www.jstor.org/stable/30086937, XP055163666 [Y] 1-18 * See e.g. the abstract; and last paragraph of the discussion. *
SEARCH- G. RAJAM ET AL, "Functional Antibodies to the O-Acetylated Pneumococcal Serotype 15B Capsular Polysaccharide Have Low Cross-Reactivities with Serotype 15C", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, US, (20070901), vol. 14, no. 9, doi:10.1128/CVI.00184-07, ISSN 1556-6811, pages 1223 - 1227, XP055640637 [Y] 17-18 * See e.g. the abstract. *
SEARCH- VAN SELM SASKIA ET AL, "Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides.", INFECTION AND IMMUNITY, (200311), vol. 71, no. 11, ISSN 0019-9567, pages 6192 - 6198, XP009517104 [Y] 17-18 * See e.g. the abstract. *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents